In anticipation of the mandated registration of clinical research organizations (CROs) starting next month, the Central Drug Regulator has set up the Sugam portal to facilitate online registration of the enterprises.
Glenmark Pharmaceuticals Ltd's share price is trading at Rs 1380.8, up 3.49% on the day as of 12:49 eastern standard time on NSE. The stock has arisen significantly in the past...
India to finalize a report this month on the list of drugs to be switched from prescription-based to OTC status. The subcommittee formed to review...
Senores Pharmaceuticals, based out of Gujarat, signed a memorandum of understanding with Dr Reddy's Laboratories regarding the sale of 14...
AstraZeneca Pharma India Ltd has received the approval from the Central Drugs Standard Control Organisation (CDSCO) to launch and import its cancer treatment Durvalumab (Imfinzi) in India. In a regulatory filing, the company noted that the approval i
Zydus Lifesciences Limited declared its intention to concentrate on creating a vaccine that covers both typhoid and shigellosis.
A total of 39 Indian pharmaceutical firms engaged with over 50 Vietnamese partners, participating in productive discussions at an ‘India-Vietnam Business-to-Business (B2B)’ meeting focused on the pharmaceutical sector...
Akums Drugs & Pharmaceuticals, India's leading contract development and manufacturing organization (CDMO), has signed a Memorandum of Understanding (MOU) with the National Institute of Food Technology, Entrepreneurship and Management – Thanjavur...
Glenmark Pharmaceuticals Ltd has also established itself in the US market by acquiring Aspen Pharma USA Inc's generic injectable Acetylcysteine. The acquisition, whose value remains confidential, aligns with Glenmark's strategy to enhance its hospita
In India, a Memorandum of Understanding (MoU) was signed by Philips, a leader in health technology, and Medtronic, a leader in medical technology, to teach and train radiologists and cardiologists in new imaging methods for structural heart disorders